<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2022.80.21</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-306</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНАЯ ТЕМА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ACTUAL TOPIC</subject></subj-group></article-categories><title-group><article-title>Дисбаланс липидов у жителей г. Якутска при инфицировании вирусом SARS-COV-2 и в постковидный период</article-title><trans-title-group xml:lang="en"><trans-title>Lipid imbalance in Yakutsk residents when infected with the SARS-CoV-2  virus and in the post-covid period</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яковлева</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakovleva</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яковлева Александра Ивановна – н.с.</p></bio><bio xml:lang="en"><p>akovleva Alexandra Ivanovna – researcher, Laboratory of Biochemical and Immunological Research</p></bio><email xlink:type="simple">sashyak@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олесова</surname><given-names>Л. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Olesova</surname><given-names>L D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олесова Любовь Дыгыновна – в.н.с.</p></bio><bio xml:lang="en"><p>Olesova Lyubov Dygynovna – external researcher, Laboratory of Biochemical and Immunological Research</p></bio><email xlink:type="simple">oles59@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Охлопкова</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Okhlopkova</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Охлопкова Елена Дмитриевна – с.н.с.</p></bio><bio xml:lang="en"><p>Okhlopkova Elena Dmitrievna – senior researcher, Laboratory of Biochemical and Immunological Research</p></bio><email xlink:type="simple">elena_okhlopkova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Якутский научный центр комплексных медицинских проблем</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yakut Science Centre for Complex Medical Problems</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>02</month><year>2025</year></pub-date><volume>0</volume><issue>4</issue><fpage>79</fpage><lpage>83</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Яковлева А.И., Олесова Л.Д., Охлопкова Е.Д., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Яковлева А.И., Олесова Л.Д., Охлопкова Е.Д.</copyright-holder><copyright-holder xml:lang="en">Yakovleva A.I., Olesova L.D., Okhlopkova E.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/306">https://ymj.elpub.ru/jour/article/view/306</self-uri><abstract><p>Проведено исследование липидного обмена у жителей г. Якутска в возрасте от 20 до 72 лет, перенесших заболевание новой коронавирусной инфекцией SARS-CoV-2 сроком от 3 до 12 месяцев назад. Целью работы явилось изучение изменения показателей фракций липидов у пациентов, перенесших COVID-19, в зависимости от срока и тяжести заболевания.</p><p>По результатам исследования при инфицировании вирусом SARS-CoV-2 происходит нарушение метаболизма липидов: уровень общего холестерина снижается в остром и значимо повышается в постковидном периоде. Наиболее выраженный сдвиг липидного профиля в сторону атерогенности происходит у переболевших COVID-19 три месяца назад за счет снижения антиатерогенной фракции липидов. Дислипидемия наиболее выражена у пациентов, перенесших инфекцию с тяжелым поражением легких (50-75%), вследствие повышения атерогенных фракций липидов, что повышает риск развития кардиоваскулярных заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>According to the results of the study, when infected with the SARS-CoV-2 virus, lipid metabolism is disturbed: in the acute period of infection, the level of total cholesterol decreases, in the post-COVID period, its level significantly increases. The most pronounced shift in the lipid profile towards atherogenicity occurs in patients who recovered from COVID-19 three months ago due to a decrease in the antiatherogenic fraction of lipids. Dyslipidemia is most pronounced in patients who have had an infection with severe lung damage (50-75%) due to an increase in atherogenic lipid fractions that create a risk of atherosclerosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>липиды</kwd><kwd>дислипидемия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>lipids</kwd><kwd>dyslipidemia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Advances in HDL: Much More than Lipid Transporters / S. Ben-Aicha, L. Badimon, G. Vilahur // International Journal of Molecular Sciences. – 2020. – No. 21(3). P. 732. – DOI: 10.3390/ijms21030732.</mixed-citation><mixed-citation xml:lang="en">Ben-Aicha S, Badimon L, Vilahur G. Advances in HDL: Much More than Lipid Transporters. International Journal of Molecular Sciences. 2020; 21(3): 732. – DOI: 10.3390/ijms21030732.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic / M. Banach, P. E. Penson, Z. Fras. -Pharmacological Research. – 2020. DOI: 10.1016/j.phrs.2020.104891.</mixed-citation><mixed-citation xml:lang="en">Banach M., Penson P. E., Fras X. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research. 2020. DOI: 10.1016/j.phrs.2020.104891.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication / B. Yan, H. Chu, D. Yang [et al] // Viruses. – 2019. No. 11(1). – P. 73. DOI: 10.3390/v11010073.</mixed-citation><mixed-citation xml:lang="en">Yan B., Chu H., Yang D. [et al]. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication. Viruses. 2019; 11(1): 73. DOI: 10.3390/v11010073.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis / Y. Peng, L. Wan, C. Fan, P. Zhang [et al] // MedRxiv. 2020. DOI: 10.1101/2020.04.16.20068528</mixed-citation><mixed-citation xml:lang="en">Peng Y, Wan L., Fan C., Zhang P. [et al]. Cholesterol   Metabolism—Impacts   on   SARS-CoV-2 Infection Prognosis MedRxiv. 2020. DOI: 10.1101/2020.04.16.20068528</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection / X. Hu, D. Chen, L. Wu [et al] // Clinica Chimica Acta. – 2020. 510. – P. 105110. DOI: 10.1016/j.cca.2020.07.015.</mixed-citation><mixed-citation xml:lang="en">Hu X., Chen D., Wu L. [et al]. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clinica Chimica Acta. 2020; 510: 105-110. DOI: 10.1016/j.cca.2020.07.015.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Endothelial and antithrombotic actions of HDL / Ch. Mineo , H. Deguchi, J. H Griffin [et al] // Circulation Research. – 2006. No. 98(11). P. 1352-1364. DOI: 10.1161/01.RES.0000225982.01988.93.</mixed-citation><mixed-citation xml:lang="en">Mineo Ch, Deguchi H, Griffin J. H. [et al]. Endothelial and antithrombotic actions of HDL. Circulation Research. 2006; 98(11): 1352-1364. DOI: 10.1161/01.RES.0000225982.01988.93.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Introduction to Lipids and Lipoproteins / K. R. Feingold, B. Anawalt, A. Boyce [et al] // In: Endotext [Internet]. South Dartmouth (MA): MD Text. com, Inc. 2021. -PMID: 26247089. Bookshelf ID: NBK305896.</mixed-citation><mixed-citation xml:lang="en">Feingold K. R., Anawalt B., Boyce A. [et al]. Introduction to Lipids and Lipoproteins In: Endotext [Internet]. South Dartmouth (MA): MD Text. com, Inc. 2021. PMID: 26247089. Bookshelf ID: NBK305896.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARSCOV-2 infectivity? / M. Baglivo, M. Baronio, G. Natalini [et al] // Acta Biomed. – 2020. No. 91(1). P. 161-164. DOI: 10.23750/abm.v91i1.9402.</mixed-citation><mixed-citation xml:lang="en">Baglivo M., Baronio M., Natalini G. [et al]. Natural small molecules as inhibitors of coronavirus lipid-dependent  attachment  to  host  cells: a  possible  strategy  for  reducing  SARS-COV-2 infectivity? Acta Biomed. 2020; 91(1): 161-164. DOI: 10.23750/abm.v91i1.9402.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission / N.J. Wierdsma, H.M. Kruizenga, L.A. Konings [et al] // Clin Nutr ESPEN. – 2021. Jun; 43: P. 369-376. doi: 10.1016/j.clnesp.2021.03.021. Epub 2021 Apr 20. PMID: 34024542; PMCID: PMC8056328.</mixed-citation><mixed-citation xml:lang="en">Wierdsma NJ, Kruizenga HM, Konings LA [et al]. Poor nutritional status, risk of sarcopenia and nutrition  related  complaints  are  prevalent in COVID-19 patients  during  and  after  hospital admission. Clin Nutr ESPEN. 2021. Jun; 43: 369-376. doi: 10.1016/j.clnesp.2021.03.021. Epub 2021 Apr 20. PMID: 34024542; PMCID: PMC8056328.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Prognostic value of PCSK9 and blood lipid in patients with sepsis / X. Chen, X. Huang, H. Tian [et al] // Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. – 2022. No. 34(6). – P.614-619. DOI: 10.3760/cma.j.cn121430-20211220-01887.</mixed-citation><mixed-citation xml:lang="en">Chen X., Xiao Huang, Tian H. [et al]. Prognostic value of PCSK9 and blood lipid in patients with sepsis. Kong Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022; 34(6): 614-619. DOI: 10.3760/cma.j.cn121430-20211220-01887.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target / M. Abu-Farha, Th. A. Thanaraj, M. G. Qaddoumi [et al] // International Journal of Molecular Sciences. – 2020. No. 21(10). DOI: 10.3390/ijms21103544.</mixed-citation><mixed-citation xml:lang="en">Abu-Farha M., Thanaraj Th. A., Qaddoumi M. G. [et al]. Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. International Journal of Molecular Sciences. 2020; 21(10). DOI: 10.3390/ijms21103544.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
